431 - 440 out of 459Page size: 10
  1. 2005

  2. Comparison CCR5del32 mutation in the CCR5 gene frequencies in Russians, Tuvinians, and in groups of HIV-infected individuals

    Apryatin, S. A., Rakhmanaliev, E. R., Nikolaeva, I. A., Ruban, S. V., Vazykhova, F. G., Klimov, E. A., Sulimova, G. E. & Sidorovich, I. G., 1 Nov 2005, In: Russian Journal of Genetics. 41, 11, p. 1287-1290 4 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2004

  4. Study of interaction between the polyoxidonium immunomodulator and the human immune system cells

    Dyakonova, V. A., Dambaeva, S. V., Pinegin, B. V. & Khaitov, R. M., 22 Oct 2004, In: International Immunopharmacology. 4, 13, p. 1615-1623 9 p.

    Research output: Contribution to journal › Article › peer-review

  5. The 14q restless legs syndrome locus in the French Canadian population

    Levchenko, A., Montplaisir, J. Y., Dubé, M. P., Riviere, J. B., St-Onge, J., Turecki, G., Xiong, L., Thibodeau, P., Desautels, A., Verlaan, D. J. & Rouleau, G. A., 1 Jun 2004, In: Annals of Neurology. 55, 6, p. 887-891 5 p.

    Research output: Contribution to journal › Article › peer-review

  6. TAU mutations are not a predominant cause of frontotemporal dementia in Canadian patients

    Levchenko, A., Robitaille, Y., Strong, M. J. & Rouleau, G. A., 1 Jan 2004, In: Canadian Journal of Neurological Sciences. 31, 3, p. 363-367 5 p.

    Research output: Contribution to journal › Article › peer-review

  7. 2003

  8. Izmenenie urovnia trevozhnosti u krys linii Vistar pod vliianiem sverkhslabogo rastvora rastitel'nogo alkaloida.

    Batuev, A. S. & Kurzina, N. P., 1 Sep 2003, In: Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova. 53, 5, p. 587-590 4 p.

    Research output: Contribution to journal › Article › peer-review

  9. The effect of polyoxidonium on the phagocytic activity of human peripheral blood leukocytes

    Dambaeva, S. V., Mazurov, D. V., Golubeva, N. M., D'Yakonova, V. A., Pinegin, B. V. & Khaitov, R. M., 1 Jan 2003, In: Central-European Journal of Immunology. 28, 2, p. 47-53 7 p.

    Research output: Contribution to journal › Article › peer-review

  10. 2002

  11. Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia.

    Kanov, E. V., Novozheeva, T. P. & Saratikov, A. S., 2002, In: Eksperimental'naia i klinicheskaia farmakologiia. 65, 2, p. 56-58 3 p.

    Research output: Contribution to journal › Article › peer-review

  12. 2001

  13. The role of D1-dependent dopaminergic mechanisms of the frontal cortex in delayed responding in rats

    Kozlov, A. P., Druzin, M. Y., Kurzina, N. P. & Malinina, E. P., 29 Aug 2001, In: Neuroscience and Behavioral Physiology. 31, 4, p. 405-411 7 p.

    Research output: Contribution to journal › Article › peer-review

  14. Possibility to enforce anti HIV candidate vaccine based on new soluble HIV recombinant antigens by polyoxidonium

    Sidorovich, I. G., Chevalier, A. F., Ignatyeva, G. A., Alekseev, T. A., Vazykhova, F. G., Korobova, S. V., Nikolaev, A. N., Apryatin, S. A., Seslavina, L. S. & Nikolaeva, I. A., 1 Jan 2001, In: Immunologiya. 2, p. 15-17 3 p.

    Research output: Contribution to journal › Article › peer-review

  15. Halodif pharmacokinetics in brain, heart, and liver

    Kanov, E. V., Novozheeva, T. P. & Saratikov, A. S., 2001, In: Pharmaceutical Chemistry Journal. 35, 9, p. 477-479 3 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1...40 41 42 43 44 45 46 Next

ID: 54572